Research Area: Infection Biological Activity: Tebipenem pivoxil(L-084) is a novel oral carbapenem antibiotic with an IC50 of 100 µg/ml for human CYP isoforms. In mouse, rat, dog and monkey, TBPM-PI were absorbed quickly, and the bioavailability was (71.4, 59.1, 34.8 and 44.9%, respectively. There was no other tissue than the kidney, in which TBPM was highly distributed and remained for a long time. In addition, low penetration to the central nervous system was confirmed. The penetration ratio of TBPM to ELF, that is the ratio of ELF concentration to plasma concentration of TBPM, was 21.8 +/- 14.7%. [1][2]
Tebipenem Pivoxil is an oral carbapenem antibiotic. Tebipenem Pivoxil is absorbed and metabolized into Tebipenem, its active metabolite which showed excellent bactericidal activity against β-lactamase-nonproducing, ampicillin-resistant isolates.
References
PubChem Literature
From Data Sources
• Kijima K et al. Jpn J Antibiot. 2009 Jun; 62(3):214-40
• Kishii, K. etal.: Antimicrob. Agents Chemother., 54, 3970 (2009)
• Nakashima, M. et al.: Nip. Kag. Ryo. Gak., 57, 90 (2009)